SYNERGY™ & SYNERGY MEGATRON™

Everolimus-Eluting Platinum Chromium Coronary Stent System

SENIOR Trial

Studying 1-month DAPT in stable elderly patients and 6-month DAPT in unstable elderly patients undergoing PCI with the SYNERGY™ BP-DES or REBEL™ BMS.

Explore

Trial Design1

SENIOR trial
 

Safety Data at 2 Years

The SYNERGY™ BP Stent continued to show superior results versus REBEL™ BMS with short BMS-like DAPT regimen at 2 years.
SENIOR trial Safety data at 2 years
 

Safety and Primary Endpoint Data at 1 Year

The SYNERGY BP Stent showed significantly lower MACCE** rates versus REBEL BMS at 1 year.
Safety and Primary Endpoint Data at 1 Year
 
Optimal Healing

Optimal Healing

Advanced design for optimal healing

Button
Real-World

Real-World Studies

How design impacts economic value

Button
Top